The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial
Citation
Klein, K., McClure, E., Colaci, D., Thorsten, V., Hibberd, P. L., Esamai, F., ... Althabe, F. (2016). The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial. Reproductive Health, 13, e64. DOI: 10.1186/s12978-016-0179-z
Abstract
BACKGROUND: The Antenatal Corticosteroid Trial (ACT) assessed the feasibility, effectiveness, and safety of a multifaceted intervention to increase the use of antenatal corticosteroids (ACS) in mothers at risk of preterm birth at all levels of care in low and middle-income countries. The intervention effectively increased the use of ACS but had no overall impact on neonatal mortality in the targeted